Atlas Trials

A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds

Clinical trial NCT02284360 · COMPLETED

Trial details

NCT number
NCT02284360
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyArtificial Dermal Wound
Start date
2014-10-01
Primary completion
2015-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.